Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
China
· Delayed Price · Currency is CNY 11.71
-0.08 (-0.68%)
Mar 11, 2026, 11:29 AM CST
SHA:603811 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,746 | 2,527 | 3,394 | 3,271 | 3,794 | 3,857 | Upgrade
|
| Market Cap Growth | 41.28% | -25.55% | 3.77% | -13.80% | -1.64% | 25.69% | Upgrade
|
| Enterprise Value | 3,664 | 2,635 | 3,600 | 3,489 | 3,857 | 3,958 | Upgrade
|
| Last Close Price | 11.79 | 7.51 | 9.80 | 9.31 | 10.60 | 10.63 | Upgrade
|
| PE Ratio | 16.82 | 12.59 | 20.84 | 20.24 | 22.22 | 23.36 | Upgrade
|
| PS Ratio | 4.74 | 3.54 | 5.05 | 4.99 | 5.47 | 5.09 | Upgrade
|
| PB Ratio | 2.82 | 2.00 | 2.84 | 3.00 | 3.80 | 4.35 | Upgrade
|
| P/TBV Ratio | 2.95 | 2.11 | 3.02 | 3.21 | 4.15 | 4.83 | Upgrade
|
| P/FCF Ratio | 13.57 | 17.33 | 27.39 | - | 404.58 | 113.02 | Upgrade
|
| P/OCF Ratio | 12.58 | 12.28 | 17.43 | 19.71 | 26.44 | 21.70 | Upgrade
|
| EV/Sales Ratio | 4.63 | 3.69 | 5.36 | 5.33 | 5.56 | 5.22 | Upgrade
|
| EV/EBITDA Ratio | 13.18 | 12.09 | 18.18 | 19.73 | 18.50 | 18.63 | Upgrade
|
| EV/EBIT Ratio | 21.57 | 21.35 | 29.83 | 30.25 | 25.08 | 24.05 | Upgrade
|
| EV/FCF Ratio | 13.28 | 18.07 | 29.05 | - | 411.29 | 115.96 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.18 | 0.37 | 0.39 | 0.15 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 0.42 | 1.06 | 2.23 | 2.40 | 0.71 | 0.57 | Upgrade
|
| Debt / FCF Ratio | 0.42 | 1.58 | 3.58 | - | 15.84 | 3.54 | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | 0.05 | 0.13 | 0.20 | 0.07 | 0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.32 | 0.27 | 0.76 | 1.21 | 0.31 | 0.23 | Upgrade
|
| Net Debt / FCF Ratio | -0.32 | 0.40 | 1.21 | -2.45 | 6.95 | 1.43 | Upgrade
|
| Asset Turnover | 0.45 | 0.40 | 0.37 | 0.43 | 0.55 | 0.69 | Upgrade
|
| Inventory Turnover | 1.88 | 1.81 | 2.18 | 1.91 | 1.77 | 1.90 | Upgrade
|
| Quick Ratio | 0.92 | 0.87 | 1.14 | 1.18 | 0.66 | 0.67 | Upgrade
|
| Current Ratio | 1.44 | 1.35 | 1.51 | 1.69 | 1.17 | 1.24 | Upgrade
|
| Return on Equity (ROE) | 17.72% | 16.31% | 14.17% | 15.43% | 18.17% | 19.93% | Upgrade
|
| Return on Assets (ROA) | 6.05% | 4.26% | 4.18% | 4.74% | 7.60% | 9.41% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.14% | 8.51% | 8.48% | 9.58% | 13.34% | 18.26% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.00% | 8.60% | 7.80% | 7.90% | 14.30% | 16.80% | Upgrade
|
| Earnings Yield | 6.04% | 7.94% | 4.80% | 4.94% | 4.50% | 4.28% | Upgrade
|
| FCF Yield | 7.37% | 5.77% | 3.65% | -2.66% | 0.25% | 0.89% | Upgrade
|
| Dividend Yield | 2.17% | 3.33% | 2.04% | 1.92% | 1.68% | 1.68% | Upgrade
|
| Payout Ratio | 37.62% | 38.21% | 45.40% | 42.57% | 36.81% | 31.72% | Upgrade
|
| Buyback Yield / Dilution | 0.78% | -0.99% | 1.20% | -0.67% | -0.59% | 0.09% | Upgrade
|
| Total Shareholder Return | 2.95% | 2.34% | 3.24% | 1.25% | 1.10% | 1.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.